Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



What Pall Corporation's Earnings Say About the Industrial Sector

Filtration and separation company Pall Corporation (NYSE: PLL  ) is not often discussed by the investment community, but that doesn't mean that Fools should ignore it. On the contrary, it's one of the most interesting stocks in the industrial sector, as its outlook usually contains a useful read across many industries. In addition, it competes with the units of some giant conglomerates, such as General Electric Company (NYSE: GE  ) and 3M Company (NYSE: MMM  ) , as well as smaller companies like Donaldson Company, Inc. (NYSE: DCI  ) and Entegris, Inc. (NASDAQ: ENTG  ) , so its commentary is relevant to them as well.

Pall Corporation's recent second-quarter results
The company's sales were evenly split between life sciences and industrial segments in 2013. The two segments provide Pall Corporation with a nice mix of health care stability and cyclical industrial growth, while its razor-and-blade model means that it can generate long-term sales from consumables (87% of its sales in 2013) provided it expands its installed systems sales.

A quick look at its recent second-quarter sales versus orders demonstrates the underlying trends in the business:

Source: Company presentations

Clearly, the life science segment is outperforming, with total segment sales up 8.3% compared to 0.1% for the industrial segment. Moreover, a breakdown of the three individual components of each segment, demonstrates where the individual industry strengths and weaknesses are.

Business Sales ($K) Change in Constant Currency
Bio-pharmaceuticals 218,625 9.1%
Food & Beverage 44,054 (0.4)%
Medical 56,660 6.6%
Process Technologies 139,664 (0.3)%
Aerospace 53,322 (12.3)%
Microelectronics 76,976 19.5%

Source: Company presentations

Life science segment
Pall Corporation competes with 3M Purification (the company contributes 6% of 3M's industrial sales) in the biopharma and food and beverage markets, and 3M recorded "good growth" with the company in its recent fourth quarter. Pall also competes with GE Healthcare in the biopharma and medical markets. With regard to the biopharna segment, Pall's management outlined that the its solutions tended to be downstream (production end rather than research and development) , but with big pharma being forced to invest in order to overcome the so-called patent cliff in 2014, it's reasonable to expect good growth in research spending to translate into drug production in future years.

Moreover, end demand appears to be relatively stable for now. Indeed, according to Pall Corporation CEO Lawrence Kingsley, "We didn't see a tremendous fall-off in the back half of last year associated with Big Pharma change dynamics, and we are not seeing a huge pickup".

Industrial segment
This segment needs some explanation, because the commentary about the results doesn't necessarily correlate with what the data in the chart above is suggesting. Among Pall Corporation's key competitors in the segment are General Electric (process, aerospace), Donaldson (process, aerospace), 3M (process), and Entegris (microelectronics).

Unfortunately, its largest industrial business (process) is the one with the worst underlying conditions. Pall management affirmed that it hadn't "seen a rebound in industrial capacity expansion" spending, and neither was productivity-based investment "improving in the manner that it had hoped". In fact, Donaldson's management told a similar story around its recent second-quarter results, with its sales of industrial filtration solutions only growing 1%, amid "weak manufacturing capital spending levels".

The decline in aerospace sales was somewhat confusing, because aftermarket sales have been strong for companies like General Electric. However, the weakness was partly due to a tough comparison last year, which contained large non-repeating aftermarket sales. Ultimately, management expects the aerospace pipeline to be strong; in other words, expect some strengthening.

On the other hand, the strength in microelectronics is also somewhat misleading. It would be wonderful for investors in the semiconductor sector (and not least Pall's rival filtration company, Entegris) to conclude that Pall's strong numbers mark a renaissance in the industry. However, management outlined that it was seeing sales strength thanks to its new products, rather than any indication of an uptick in long-term growth. In fact, there was some negative commentary on industry capacity.

Interestingly, Entegris is also likely to achieve growth, but this is because it agreed to buy semiconductor ATMI Inc. in February, with Pall Corporation picking up ATMI's life science business.

The bottom line
In conclusion, Pall Corporation's results indicate strength in biopharma spending, but ongoing sluggishness in industrial capital spending. Process technology spending remains weak, but aerospace should strengthen for Pall. However, the microelectronics industry remains in the doldrums, and Fools should not get too excited, too soon.

As for Pall Corporation itself, the company is undoubtedly attractive, but with a forward P/E ratio of around 25 times its full year earnings to July 2014, it's hardly cheap. Especially when its second-biggest business isn't seeing strong end markets. However, the strength in life sciences spending should be noted by Foolish investors.

There’s a huge difference between a good stock and one that can make you rich
The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it’s one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 06, 2014, at 12:53 PM, john34howard wrote:

    It looks like this sector could use some work, but there is promise that it is going to show good results. I have some different interests in this sector and I have high hopes for it in the future. Thanks for sharing this article because it really helped me get perspective on what is going on.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2876134, ~/Articles/ArticleHandler.aspx, 8/29/2015 7:54:08 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Lee Samaha

Investing commentary to help retail investors outperform professionals. I research and write post-earnings analysis of leading companies. Follow me on Twitter or Google+ to receive quick and thorough earnings analysis of your favorite stocks.

Today's Market

updated 22 hours ago Sponsored by:
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 1.21 0.06%
NASD 4,828.33 15.62 0.32%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/28/2015 4:03 PM
PLL $127.11 Down -0.01 -0.01%
Pall Corp CAPS Rating: **
DCI $31.57 Up +0.11 +0.35%
Donaldson Company,… CAPS Rating: ***
ENTG $13.70 Up +0.02 +0.15%
Entegris, Inc. CAPS Rating: *****
GE $25.16 Up +0.15 +0.60%
General Electric C… CAPS Rating: ****
MMM $144.21 Up +0.31 +0.22%
3M CAPS Rating: ****